bpc-157 shoulder injury dosage stability of bpc 157 peptide in solution at room temperature for Injuries: Dosing & Recovery Guide BPC 157 BPC-157 vs TB-500: Recovery Peptide

The data is improving, the regulatory environment is more favorable, and the safety profile remains strong

Some patients notice improved sleep and energy within a few weeks, while body composition changes and tissue repair improvements may take 24 months of consistent use

That is the most substantial human outcome data currently available for a compound that people are sourcing and injecting based on internet research.[4,5] BPC-157 has been used in Phase II trials for ulcerative colitis and multiple sclerosis.[1,2] Comprehensive published results from those trials are not available in the medical literature

"Not FDA-approved" just means the FDA hasn't reviewed or signed off on its safety, efficacy, dosing, or manufacturing for people